Literature DB >> 18268325

IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation.

Pascal Descargues1, Alok K Sil, Yuji Sano, Olexandr Korchynskyi, Gangwen Han, Philip Owens, Xiao-Jing Wang, Michael Karin.   

Abstract

Cell-cycle exit and differentiation of suprabasal epidermal keratinocytes require nuclear IkappaB kinase alpha (IKKalpha), but not its protein kinase activity. IKKalpha also is a suppressor of squamous cell carcinoma (SCC), but its mode of action remains elusive. Postulating that IKKalpha may serve as a transcriptional regulator in keratinocytes, we searched for cell-cycle-related genes that could illuminate this function. IKKalpha was found to control several Myc antagonists, including Mad1, Mad2, and Ovol1, through the association with TGFbeta-regulated Smad2/3 transcription factors and is required for Smad3 recruitment to at least one of these targets. Surprisingly, Smad2/3-dependent Mad1 induction and keratinocyte differentiation are independent of Smad4, the almost universal coregulator of canonical TGFbeta signaling. IKKalpha also is needed for nuclear accumulation of activated Smad2/3 in the epidermis, and Smad2/3 are required for epidermal differentiation. We suggest that a TGFbeta-Smad2/3-IKKalpha axis is a critical Smad4-independent regulator of keratinocyte proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268325      PMCID: PMC2268163          DOI: 10.1073/pnas.0712044105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.

Authors:  S D Westerheide; M W Mayo; V Anest; J L Hanson; A S Baldwin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 2.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

3.  In utero activation of K5.CrePR1 induces gene deletion.

Authors:  Zhijian Zhou; Dongyan Wang; Xiao-Jing Wang; Dennis R Roop
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

4.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 5.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

6.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

Authors:  C Makris; V L Godfrey; G Krähn-Senftleben; T Takahashi; J L Roberts; T Schwarz; L Feng; R S Johnson; M Karin
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

7.  Deregulated expression of c-Myc depletes epidermal stem cells.

Authors:  R L Waikel; Y Kawachi; P A Waikel; X J Wang; D R Roop
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

8.  The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.

Authors:  S Werner; H D Beer; C Mauch; B Lüscher; S Werner
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

9.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

10.  Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression.

Authors:  Genta Maeda; Tadashige Chiba; Shuichi Kawashiri; Tazuko Satoh; Kazushi Imai
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

View more
  83 in total

Review 1.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

2.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 3.  Role of IKKα in skin squamous cell carcinomas.

Authors:  Eunmi Park; Bigang Liu; Xiaojun Xia; Feng Zhu; Willette-Brown Jami; Yinling Hu
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

4.  Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors.

Authors:  D De Silva; M D Mitchell; J A Keelan
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 5.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

6.  Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis.

Authors:  Feng Zhu; Jami Willette-Brown; Na-Young Song; Dakshayani Lomada; Yongmei Song; Liyan Xue; Zane Gray; Zitong Zhao; Sean R Davis; Zhonghe Sun; Peilin Zhang; Xiaolin Wu; Qimin Zhan; Ellen R Richie; Yinling Hu
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

7.  Ovol2 suppresses cell cycling and terminal differentiation of keratinocytes by directly repressing c-Myc and Notch1.

Authors:  Julie Wells; Briana Lee; Anna Qianyao Cai; Adrine Karapetyan; Wan-Ju Lee; Elizabeth Rugg; Satrajit Sinha; Qing Nie; Xing Dai
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

8.  The Groucho protein Grg4 suppresses Smad7 to activate BMP signaling.

Authors:  Peng Zhang; Gregory R Dressler
Journal:  Biochem Biophys Res Commun       Date:  2013-10-05       Impact factor: 3.575

9.  The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.

Authors:  Barbara Marinari; Francesca Moretti; Elisabetta Botti; Maria Laura Giustizieri; Pascal Descargues; Alessandro Giunta; Carmine Stolfi; Costanza Ballaro; Marina Papoutsaki; Stefano Alemà; Giovanni Monteleone; Sergio Chimenti; Michael Karin; Antonio Costanzo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

Review 10.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.